These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 9199201

  • 1. Photoaffinity labeling of yeast farnesyl protein transferase and enzymatic synthesis of a Ras protein incorporating a photoactive isoprenoid.
    Edelstein RL, Distefano MD.
    Biochem Biophys Res Commun; 1997 Jun 18; 235(2):377-82. PubMed ID: 9199201
    [Abstract] [Full Text] [Related]

  • 2. Biochemical and structural studies with prenyl diphosphate analogues provide insights into isoprenoid recognition by protein farnesyl transferase.
    Turek-Etienne TC, Strickland CL, Distefano MD.
    Biochemistry; 2003 Apr 08; 42(13):3716-24. PubMed ID: 12667062
    [Abstract] [Full Text] [Related]

  • 3. Involvement of the alpha subunit of farnesyl-protein transferase in substrate recognition.
    Pellicena P, Scholten JD, Zimmerman K, Creswell M, Huang CC, Miller WT.
    Biochemistry; 1996 Oct 15; 35(41):13494-500. PubMed ID: 8873619
    [Abstract] [Full Text] [Related]

  • 4. Functional consequence of mutating conserved residues of the yeast farnesyl-protein transferase beta-subunit Ram1(Dpr1).
    Kurth DD, Farh L, Deschenes RJ.
    Biochemistry; 1997 Dec 16; 36(50):15932-9. PubMed ID: 9398327
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB, Silverman KC, Jayasuriya H, Kim BM, Amo SE, Wilson FR, Rew DJ, Schaber MD, Bergstrom JD, Koblan KS, Graham SL, Kohl NE, Gibbs JB, Singh SB.
    J Med Chem; 1998 Nov 05; 41(23):4492-501. PubMed ID: 9804689
    [Abstract] [Full Text] [Related]

  • 7. Photoreactive analogues of prenyl diphosphates as inhibitors and probes of human protein farnesyltransferase and geranylgeranyltransferase type I.
    Bukhtiyarov YE, Omer CA, Allen CM.
    J Biol Chem; 1995 Aug 11; 270(32):19035-40. PubMed ID: 7642565
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protein farnesyltransferase: measurement of enzymatic activity in 96-well format using TopCount microplate scintillation counting technology.
    Harwood HJ.
    Anal Biochem; 1995 Apr 10; 226(2):268-78. PubMed ID: 7793628
    [Abstract] [Full Text] [Related]

  • 10. Characterization of recombinant human farnesyl-protein transferase: cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferases.
    Omer CA, Kral AM, Diehl RE, Prendergast GC, Powers S, Allen CM, Gibbs JB, Kohl NE.
    Biochemistry; 1993 May 18; 32(19):5167-76. PubMed ID: 8494894
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin.
    Chen X, Hasuma T, Yano Y, Yoshimata T, Morishima Y, Wang Y, Otani S.
    Anticancer Res; 1997 May 18; 17(4A):2555-64. PubMed ID: 9252680
    [Abstract] [Full Text] [Related]

  • 12. Photoaffinity-labeling peptide substrates for farnesyl-protein transferase and the intersubunit location of the active site.
    Ying W, Sepp-Lorenzino L, Cai K, Aloise P, Coleman PS.
    J Biol Chem; 1994 Jan 07; 269(1):470-7. PubMed ID: 8276838
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB, Omer CA, Abrams MT, Bhimnathwala HG, Brucker MJ, Buser CA, Davide JP, deSolms SJ, Dinsmore CJ, Ellis-Hutchings MS, Kral AM, Liu D, Lumma WC, Machotka SV, Rands E, Williams TM, Graham SL, Hartman GD, Oliff AI, Heimbrook DC, Kohl NE.
    Cancer Res; 2001 Dec 15; 61(24):8758-68. PubMed ID: 11751396
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Modification of Rab5 with a photoactivatable analog of geranylgeranyl diphosphate.
    Quellhorst GJ, Allen CM, Wessling-Resnick M.
    J Biol Chem; 2001 Nov 02; 276(44):40727-33. PubMed ID: 11522782
    [Abstract] [Full Text] [Related]

  • 16. Isoprenoid diphosphate utilization by recombinant human farnesyl:protein transferase: interactive binding between substrates and a preferred kinetic pathway.
    Pompliano DL, Schaber MD, Mosser SD, Omer CA, Shafer JA, Gibbs JB.
    Biochemistry; 1993 Aug 17; 32(32):8341-7. PubMed ID: 8347630
    [Abstract] [Full Text] [Related]

  • 17. Photoaffinity analogues of farnesyl pyrophosphate transferable by protein farnesyl transferase.
    Chehade KA, Kiegiel K, Isaacs RJ, Pickett JS, Bowers KE, Fierke CA, Andres DA, Spielmann HP.
    J Am Chem Soc; 2002 Jul 17; 124(28):8206-19. PubMed ID: 12105898
    [Abstract] [Full Text] [Related]

  • 18. Oreganic acid, a potent inhibitor of ras farnesyl-protein transferase.
    Silverman KC, Jayasuriya H, Cascales C, Vilella D, Bills GF, Jenkins RG, Singh SB, Lingham RB.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):478-81. PubMed ID: 9125205
    [Abstract] [Full Text] [Related]

  • 19. Synergy between anions and farnesyldiphosphate competitive inhibitors of farnesyl:protein transferase.
    Scholten JD, Zimmerman KK, Oxender MG, Leonard D, Sebolt-Leopold J, Gowan R, Hupe DJ.
    J Biol Chem; 1997 Jul 18; 272(29):18077-81. PubMed ID: 9218438
    [Abstract] [Full Text] [Related]

  • 20. Farnesyl-derived inhibitors of ras farnesyl transferase.
    Kang MS, Stemerick DM, Zwolshen JH, Harry BS, Sunkara PS, Harrison BL.
    Biochem Biophys Res Commun; 1995 Dec 05; 217(1):245-9. PubMed ID: 8526918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.